HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunogenicity of decidual stromal cells in an epidermolysis bullosa patient and in allogeneic hematopoietic stem cell transplantation patients.

Abstract
Allogeneic mesenchymal stromal cells (MSCs) are widely used in regenerative medicine, but little is known about their immunogenicity. In this study, we monitored the therapeutic and immunogenic effects of decidual stromal cells (DSCs) from term placentas when used as a therapy for generalized severe junctional epidermolysis bullosa (JEB) (previously termed Herlitz JEB), a lethal condition caused by the lack of functional laminin-332. An 11-month-old JEB patient was treated with five infusions of allogeneic DSCs within a 3-month period. Amniotic membranes (AMs) were applied to severe wounds. After the treatment, wounds started to heal in the middle of the blisters, but the improvements were transient. After two infusions of DSCs, the JEB patient had developed multispecific anti-HLA class-I antibodies. No antibodies to laminin-332 were detected, but the patient had high levels of anti-bovine serum albumin antibodies, which could bind to DSCs. Peripheral blood mononuclear cells (PBMCs) from the patient had a higher proliferative response to DSCs than to third-party PBMCs, which contrasts with the pattern observed in healthy donors. Human DSCs and MSCs induced similar xenoreactivity in mice. Two of 16 allogeneic stem cell-transplanted patients, treated with DSCs for graft-versus-host disease or hemorrhagic cystitis, showed a positive flow cytometric crossmatch test. One patient had anti-HLA antibodies before DSC infusion, whereas the other had no anti-HLA antibodies at any time. AM and DSC infusions may have improved the healing process in the JEB patient, but DSCs appeared to induce anti-HLA antibodies. The risk of alloimmunization by DSCs seems to be low in immunocompromised patients.
AuthorsHelen Kaipe, Lena-Maria Carlson, Tom Erkers, Silvia Nava, Pia Molldén, Britt Gustafsson, Hua Qian, Xiaoguang Li, Takashi Hashimoto, Behnam Sadeghi, Mats Alheim, Olle Ringdén
JournalStem cells and development (Stem Cells Dev) Vol. 24 Issue 12 Pg. 1471-82 (Jun 15 2015) ISSN: 1557-8534 [Electronic] United States
PMID25658253 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Anti-Idiotypic
  • Cell Adhesion Molecules
  • HLA Antigens
  • kalinin
  • Serum Albumin, Bovine
Topics
  • Adolescent
  • Adult
  • Aged
  • Animals
  • Antibodies, Anti-Idiotypic (blood, immunology)
  • Cell Adhesion Molecules (blood, immunology)
  • Child
  • Decidua (immunology, transplantation)
  • Epidermolysis Bullosa (immunology, pathology, therapy)
  • Female
  • Graft vs Host Disease (etiology, immunology, pathology)
  • HLA Antigens (immunology)
  • Hematopoietic Stem Cell Transplantation (adverse effects)
  • Heterografts (immunology)
  • Humans
  • Immunogenetic Phenomena
  • Infant
  • Leukocytes, Mononuclear (immunology, transplantation)
  • Male
  • Mesenchymal Stem Cell Transplantation (adverse effects)
  • Mesenchymal Stem Cells (immunology)
  • Mice
  • Middle Aged
  • Serum Albumin, Bovine (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: